Open Access
Planta Medica Letters 2016; 3(01): e14-e16
DOI: 10.1055/s-0035-1568355
Letter
Georg Thieme Verlag KG Stuttgart · New York

Antiproliferative Butyrolactones from Mezilaurus crassiramea

Authors

  • Danilo Tófoli

    1   Instituto de Química, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
  • Laura Alves Verão Martins

    2   Centro de Ciências Biológicas e da Saúde, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
  • Maria de Fátima Cepa Matos

    2   Centro de Ciências Biológicas e da Saúde, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
  • Walmir Silva Garcez

    1   Instituto de Química, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
  • Fernanda Rodrigues Garcez

    1   Instituto de Química, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
Further Information

Publication History

received 14 August 2015
revised 14 August 2015

accepted 15 January 2016

Publication Date:
11 February 2016 (online)

Abstract

Bioassay-guided fractionation of the ethanol extract from the leaves of Mezilaurus crassiramea, which was toxic to Artemia salina larvae, afforded 3′-acetylrubrenolide (1), 2′,3′-diacetylrubrenolide (2), and rubrenolide (3) from the active dichloromethane soluble fraction. Compound 1 is new, while 2 and 3 are first reported from a natural source and in the Mezilaurus genus, respectively. Compound 3 showed significant cytotoxicity against UACC-62, MCF-7, HT-29, and PC-3 human cancer cell lines, with GI50 values ranging from 3.3 to 9.9 µg/mL, while 1 and 2 exhibited marginal activities against at least five of the six investigated cell lines. The structures of 13 were established on the basis of 1D- and 2D-nuclear magnetic resonance analyses, high-resolution electrospray ionization mass spectrometry data and specific optical rotation values.